Skip to main content
. 2022 Aug 26;15:6821–6836. doi: 10.2147/IJGM.S376316

Figure 4.

Figure 4

A column presentation compared duration of adverse reactions reported after 2nd and 3rd Pfizer-BioNTech vaccine doses. Data were presented as the percentage of individuals who have reported a particular duration relative to the total number of individuals who have experienced the adverse reactions (n=340 for the 2nd dose and 349 for 3rd dose). p value derived from Fisher’s exact test.